Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTOR: Corticosteroids + Rivaroxaban vs Corticosteroids Alone in DVT of Behçet's Syndrome
NCT06780462Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in Behçet's disease (BD), deep vein thrombosis (DVT), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2025; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
Behçet's disease (BD)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT06780462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06780462.